SEC Tracker
Get the app

McKESSON MCK

McKesson reports $1.22 billion net income for fiscal Q2 2027

Form
10-Q
Filed
Importance
Notable
  1. Revenue of $110.96 billion for the three months ended Sep 30, 2026
  2. Net income of $1.22 billion for the three months ended Sep 30, 2026
  3. Diluted EPS of $10.44 for the three months ended Sep 30, 2026
  4. Cash and equivalents of $6.53 billion as of Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when McKESSON files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

  1. The financial statements source reports revenue of $111.0 billion and net income of $1.2 billion, with revenue up +7.6% from a year earlier.
  2. Operating income was $1,604 million, compared with $1,407 million.
  3. Net income attributable to McKesson Corporation was $1,218 million for the quarter.
  4. Diluted earnings per share were $10.44, compared with $8.92 for the same quarter of 2025.
  5. Diluted weighted-average shares were 116.7 million, against 124.4 million.
  6. For the six months ended September 30, 2026, revenues were $216,337 million and net income attributable to McKesson Corporation was $1,832 million.
  7. Net income attributable to noncontrolling interests was $496 million for that period, against $100 million a year earlier.
  8. The balance sheet shows cash and cash equivalents of $6,528 million at September 30, 2026, against $3,975 million at March 31, 2026.
  9. Long-term debt was $8,414 million, versus $5,259 million.
  10. The quarter included repurchases of common stock of $1,120 million in treasury shares and cash dividends declared of $0.94 per common share.

10 of 10 claims matched the filing text.

From the filing

Item 1. Condensed Consolidated Financial Statements.

Item 1. Condensed Consolidated Financial Statements.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share amounts)

(Unaudited)

Three Months Ended September 30, Six Months Ended September 30,

2026 2025 2026 2025 Revenues $ 110,9571 $ 103,150 $ 216,337 $ 200,9776 Cost of sales ( 107,001 ) ( 99,608 ) ( 208,696 ) ( 194,156 ) Gross profit 3,956 3,542 7,641 6,821 Selling, distribution, general, and administrative expenses ( 2,269 ) ( 2,074 ) ( 4,533 ) ( 4,270 ) Claims and litigation charges, net 2 2 36 2 Restructuring, impairment, and related charges, net ( 85 ) ( 63 ) ( 221 ) ( 110 ) Total operating expenses ( 2,352 ) ( 2,135 ) ( 4,718 ) ( 4,378 ) Operating income 1,604 1,407 2,923 2,4432 Other income, net 63 62 129 126 Interest expense ( 105 ) ( 74 ) ( 182 ) ( 123 ) Income before income taxes 1,562 1,395 2,870 2,446 Income tax expense ( 266 ) ( 232 ) ( 542 ) ( 452 ) Net income 1,296 1,163 2,328 1,994 Net income attributable to noncontrolling interests ( 78 ) ( 53 ) ( 496 ) ( 100 )7 Net income attributable to McKesson Corporation $ 1,218 $ 1,110 $ 1,832 $ 1,8943

Earnings per common share attributable to McKesson Corporation

Diluted $ 10.44 $ 8.92 $ 15.53 $ 15.164 Basic $ 10.47 $ 8.95 $ 15.59 $ 15.22

Weighted-average common shares outstanding

Diluted 116.7 124.4 117.9 124.95 Basic 116.3 124.0 117.5 124.5

See Financial Notes

3

Table of Contents

McKESSON CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In millions)

(Unaudited)

Three Months Ended September 30, Six Months Ended September 30,

2026 2025 2026 2025 Net income $ 1,296 $ 1,163 $ 2,328 $ 1,994

Other comprehensive income (loss), net of tax

Foreign currency translation adjustments ( 20 ) ( 5 ) ( 29 ) 16 Unrealized gains (loss) on cash flow and other hedges 1 ( 5 ) 6 9

Changes in retirement-related benefit plans — — — ( 1 )

Other comprehensive income (loss), net of tax ( 19 ) ( 10 ) ( 23 ) 24 Comprehensive income 1,277 1,153 2,305 2,018 Comprehensive income attributable to noncontrolling interests ( 78 ) ( 53 ) ( 496 ) ( 100 ) Comprehensive income attributable to McKesson Corporation $ 1,199 $ 1,100 $ 1,809 $ 1,918

See Financial Notes

4

Table of Contents

McKESSON CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except per share amounts)

(Unaudited)

September 30, 2026 March 31, 2026

ASSETS

Current assets

Cash and cash equivalents $ 6,528 $ 3,9758 Receivables, net 30,806 27,985 Inventories, net 28,217 24,207 Prepaid expenses and other 1,134 1,043 Total current assets 66,685 57,210

Property, plant, and equipment, net 2,665 2,668

Operating lease right-of-use assets 1,937 2,058

Goodwill 11,272 11,316 Intangible assets, net 3,942 4,079 Other non-current assets 5,822 4,992 Total assets $ 92,323 $ 82,323

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND DEFICIT

Current liabilities

Drafts and accounts payable $ 67,761 $ 59,973

Current portion of long-term debt 794 1,267

Current portion of operating lease liabilities 286 287

Other accrued liabilities 5,555 5,490 Total current liabilities 74,396 67,017 Long-term debt 8,414 5,2599

Long-term deferred tax liabilities 1,457 1,330

Long-term operating lease liabilities 1,667 1,801

Long-term litigation liabilities 4,563 5,091 Other non-current liabilities 2,842 2,659 Redeemable noncontrolling interests 2,563 943

McKesson Corporation stockholders' deficit

Preferred stock, $ 0.01 par value, 100 shares authorized, no shares issued or outstanding

— —

Common stock, $ 0.01 par value, 800 shares authorized, 280 shares issued at September 30, 2026 and March 31, 2026 3 3 Additional paid-in capital 8,907 8,284 Retained earnings 23,916 22,291 Accumulated other comprehensive loss ( 768 ) ( 745 ) Treasury shares, at cost, 165 and 160 shares at September 30, 2026 and March 31, 2026, respectively ( 36,012 ) ( 32,005 )

Total McKesson Corporation stockholders' deficit ( 3,954 ) ( 2,172 )

Noncontrolling interests 375 395 Total deficit ( 3,579 ) ( 1,777 )

Total liabilities, redeemable noncontrolling interests, and deficit

$ 92,323 $ 82,323

See Financial Notes

5

Table of Contents

McKESSON CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

(In millions, except per share amounts)

(Unaudited)

Three Months Ended September 30, 2026

Common Stock Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Loss Treasury Noncontrolling

Interests Total

Deficit

Shares Amount Common Shares Amount

Balance, June 30, 2026 280 $ 3 $ 8,588 $ 22,808 $ ( 749 ) ( 164 ) $ ( 34,890 ) $ 376 $ ( 3,864 ) Issuance of shares under employee plans, net of forfeitures — — 33 — — — ( 1 ) — 32 Share-based compensation — — 58 — — — — — 58 Repurchase of common stock — — 215 — — ( 1 ) ( 1,120 ) — ( 905 )10 Net income — — — 1,218 — — — 46 1,264 Other comprehensive loss — — — — ( 19 ) — — — ( 19 )

Cash dividends declared, $ 0.94 per common share10

— — — ( 110 ) — — — — ( 110 ) Payments to noncontrolling interests — — — — — — — ( 39 ) ( 39 )

Adjustment to fair value of redeemable noncontrolling interests — — 14 — — — — — 14

Other — — ( 1 ) — — — ( 1 ) ( 8 ) ( 10 ) Balance, September 30, 2026 280 $ 3 $ 8,907 $ 23,916 $ ( 768 ) ( 165 ) $ ( 36,012 ) $ 375 $ ( 3,579 ) Three Months Ended September 30, 2025

Common Stock Additional Paid-in Capital Retained Earnings Accumulated Other Comprehensive Loss Treasury Noncontrolling

Interests Total

Deficit

Shares Amount Common Shares Amount

Balance, June 30, 2025 280 $ 3 $ 8,449 $ 18,616 $ ( 898 ) ( 155 ) $ ( 28,137 ) $ 379 $ ( 1,588 ) Issuance of shares under employee plans, net of forfeitures — — 28 — — — ( 1 ) — 27 Share-based compensation — — 68 — — — — — 68 Repurchase of common stock — — — — — ( 1 ) ( 817 ) — ( 817 ) Net income — — — 1,110 — — — 48 1,158 Other comprehensive loss — — — — ( 10 ) — — — ( 10 )

Cash dividends declared, $ 0.82 per common share

— — — ( 103 ) — — — — ( 103 ) Payments to noncontrolling interests — — — — — — — ( 44 ) ( 44 )

Adjustment to fair value of redeemable noncontrolling interests — — ( 47 ) — — — — — ( 47

Similar companies

Companies of similar size in SIC 5122 and related industry codes: the same peer list as the financial tables.

  1. Cardinal Health CAH public float $48.2B, Dec 31, 2025
  2. Cencora COR public float $37.9B, Mar 31, 2025, over 18 months old
  3. Herbalife HLF public float $762M, Jun 30, 2025
  4. Nu Skin Enterprises NUS public float $390M, Jun 30, 2025
  5. DataMeds AI MEDS public float $27M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.